135 related articles for article (PubMed ID: 12880279)
21. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
Melana SM; Holland JF; Pogo BG
Clin Cancer Res; 1998 Mar; 4(3):693-6. PubMed ID: 9533539
[TBL] [Abstract][Full Text] [Related]
22. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
Cox SW; Albert J; Wahlberg J; Uhlén M; Wahren B
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1229-34. PubMed ID: 1520536
[TBL] [Abstract][Full Text] [Related]
23. Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.
Yasuda C; Kato M; Kuroda D; Ohyanagi H
Jpn J Cancer Res; 1997 Jan; 88(1):97-102. PubMed ID: 9045902
[TBL] [Abstract][Full Text] [Related]
24. Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Chandrasekaran B; Kute TE; Duch DS
Cancer Chemother Pharmacol; 1995; 35(6):489-95. PubMed ID: 7882457
[TBL] [Abstract][Full Text] [Related]
25. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Weidner DA; Sommadossi JP
Mol Pharmacol; 1990 Dec; 38(6):797-804. PubMed ID: 2174502
[TBL] [Abstract][Full Text] [Related]
26. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside inhibitors.
Cruchaga C; Odriozola L; Andréola M; Tarrago-Litvak L; Martínez-Irujo JJ
Biochemistry; 2005 Mar; 44(9):3535-46. PubMed ID: 15736963
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary disposition of 3'-azido-3'-deoxythymidine (AZT) in the rat: effect of phenobarbitone induction.
Bezek S; Kukan M; Bohov P
J Pharm Pharmacol; 1994 Jul; 46(7):575-80. PubMed ID: 7996386
[TBL] [Abstract][Full Text] [Related]
30. Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors.
Wagner CR; Ballato G; Akanni AO; McIntee EJ; Larson RS; Chang S; Abul-Hajj YJ
Cancer Res; 1997 Jun; 57(12):2341-5. PubMed ID: 9192804
[TBL] [Abstract][Full Text] [Related]
31. [Effects of AZT on leukemia cell line KG-1a proliferation and telomerase activity].
Jin RR; Chao R; Xi YM; Chen C; Chu HY; Li M; Zhang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):277-81. PubMed ID: 22541081
[TBL] [Abstract][Full Text] [Related]
32. 3'-Azido-3'-deoxythymidine inhibition of human lymphocyte cytolytic function in vitro.
Shaw DR; Knight DR; Waterman AL; Sommadossi JP
Biochem Pharmacol; 1991 Jan; 41(2):287-91. PubMed ID: 1989638
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
34. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
[TBL] [Abstract][Full Text] [Related]
35. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines.
Photiou A; Shah P; Leong LK; Moss J; Retsas S
Eur J Cancer; 1997 Mar; 33(3):463-70. PubMed ID: 9155533
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
Kumar R; Wang L; Wiebe LI; Knaus EE
J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
[TBL] [Abstract][Full Text] [Related]
37. Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains.
Zhu QY; Scarborough A; Polsky B; Chou TC
AIDS Res Hum Retroviruses; 1996 Apr; 12(6):507-17. PubMed ID: 8679306
[TBL] [Abstract][Full Text] [Related]
38. [Azidothymidine inhibition of telomerase activity and proliferation of TJ905 human glioblastoma cells].
Liu J; Wang Q; Yu SZ; Zhao WJ; Sun CY; An TL; Wang LL; Chen XJ
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):183-8. PubMed ID: 19575855
[TBL] [Abstract][Full Text] [Related]
39. Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.
Gomez DE; Tejera AM; Olivero OA
Biochem Biophys Res Commun; 1998 May; 246(1):107-10. PubMed ID: 9600076
[TBL] [Abstract][Full Text] [Related]
40. Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro.
Volpe DA; Du DL; Verhoef V; Murphy MJ
Pathobiology; 1993; 61(2):77-82. PubMed ID: 8216829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
